Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances Medical Device Investing
Lexston Mining Corporation Announces Phase 1 of the Garfield Hills Work Program Life Science Investing
Largest Published Study of Molecular Residual Disease in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions Life Science Investing
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer Life Science Investing
EURneffy® 1 mg Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ?15 kg to <30 kg Life Science Investing
Palvella Therapeutics Announces Scientific Publication in Clinical and Experimental Dermatology Highlighting a Systematic Review of Real-World Statin Evidence and Persistent Treatment Gaps Resulting from the Lack of FDA-Approved Therapies in Porokeratosis Life Science Investing
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm Pharmaceutical Investing
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026 Life Science Investing
Ocumetics Announces Proposed Forbearance Agreement for $4 million Secured Convertible Debentures Technology Investing
